Skip to main content
45°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Novo Nordisk A/S
Europe News
Markets
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Eli Lilly and Co
Health care industry
Healthy Returns
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Biogen Inc
Investing
Business News
From
CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
June 10, 2024
Tags
Health care industry
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
June 07, 2024
Tickers
RH
Tags
Affirm Holdings Inc
Investment Strategy
Business
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Healthy Returns
Science
Moderna Inc
From
CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
June 06, 2024
Tags
Eli Lilly and Co
Alphabet Inc
Pharmaceuticals
From
CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
June 05, 2024
Tags
Breaking News: Technology
Alphabet Inc
Eli Lilly and Co
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Social issues
Employee benefits
Weight loss diets
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Eli Lilly and Co
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
May 27, 2024
Tags
Chugai Pharmaceutical Co Ltd
U/S/ Markets
Investing
From
CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
May 25, 2024
Tags
Breaking News: Technology
Hims & Hers Health Inc
Health & Science
From
CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
May 24, 2024
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
May 23, 2024
Tags
Investment strategy
Stock Picks
Market Outlook
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Health & Science
Fusion Pharmaceuticals Inc
Investing
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
May 21, 2024
Tags
Health & Science
Uber Technologies Inc
Novo Nordisk A/S
From
CNBC.com News
Roche says weight loss drug shows promising results in early trial
May 16, 2024
Tags
Biotechnology
US: News
Companies
From
CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
May 14, 2024
Tags
Eli Lilly and Co
Science
Alphabet Inc
From
CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
May 14, 2024
Tags
Health care industry
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
May 13, 2024
Tags
Breaking News: Technology
AI / Artificial Intelligence
Tesla Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
May 07, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Health care industry
Viking Therapeutics Inc
Eli Lilly and Co
From
CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
May 05, 2024
Tags
Drugs
AI / Artificial Intelligence
Pharmaceuticals
From
CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
May 03, 2024
Tags
Health & Science
Business News
US: News
From
CNBC.com News
Wegovy maker Novo Nordisk down 4%, heads for worst day since October
May 03, 2024
Tags
Europe News
Biotech and Pharmaceuticals
Europe Markets
From
CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
May 02, 2024
Tags
Biotechnology
Companies
US: News
From
CNBC.com News
Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro
April 30, 2024
Tags
Biotech and Pharmaceuticals
Health care industry
Eli Lilly and Co
From
CNBC.com News
5 things to know before the stock market opens Monday
April 29, 2024
Tags
Coca/Cola Co
ETSY Inc
Amgen Inc
From
CNBC.com News
Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly
April 26, 2024
Tags
Wingstop Inc
Investing
Business News
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.